Dáil
Written answer
Medicinal Products
202. Deputy Michael Fitzmaurice asked the Minister for Health her views on whether the current delay in the Skyclarys reimbursement negotiations aligns with the “equitable access” promised in the newly launched National Rare Disease Strategy 2025–2030; and if she will make a statement on the matter. [30663/26]